No Data
No Data
12 Health Care Stocks Moving In Friday's After-Market Session
Express News | Tharimmune Inc - Board Expands to Nine Members - SEC Filing
Express News | Tharimmune Says FDA Confirmed No Additional Trials Appear To Be Necessary Prior To A 505(b)(2) New Drug Application Submission
Tharimmune Strengthens Strategic Leadership With the Appointment of Vincent LoPriore to Its Board of Directors
Tharimmune Reports Preclinical Data for Dual-Target Biologics
Express News | Fw: [Ext] News: Tharimmune Announces Positive Data With Novel Biparatopic Pd-1/Vegf and Multispecific Her2/Her3 Biologics Leveraging Proprietary Epiclick(Tm) Technology